Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
02/2012
02/08/2012EP2415760A2 CCR-9 antagonists
02/08/2012EP2414896A1 Actinic ray-sensitive or radiation-sensitive resin composition and pattern forming method using the same
02/08/2012EP2414343A1 Process for preparing brinzolamide
02/08/2012EP2414323A1 Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products
02/08/2012CN102348701A Branched compound, and organic thin film and organic thin film element each comprising same
02/08/2012CN102348700A Conjugated compound, and organic thin film and organic thin film element each comprising same
02/08/2012CN102348682A 1,1,1-trifluoro-2-hydroxypropyl compounds
02/08/2012CN102348674A Leukotriene b4 inhibitors
02/08/2012CN102344437A Resist composition, method of forming resist pattern, novel compound, and acid generator
02/08/2012CN101207182B 噻吩电子器件 Thiophene electronics
02/08/2012CN101039905B 新组蛋白脱乙酰基酶抑制剂 New histone deacetylase inhibitors
02/02/2012WO2012015750A2 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies
02/02/2012WO2012015265A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
02/02/2012WO2012014994A1 Naphthalene derivative
02/02/2012WO2012014943A1 Condensed ring compound, organic thin film, and organic thin film element
02/02/2012WO2012014779A1 Organic electroluminescent element and compound
02/02/2012WO2012013727A1 Cyclopropylamine derivatives useful as lsd1 inhibitors
02/02/2012US20120029212 Method for the preparation of (s)-n-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine)
02/02/2012US20120029211 Catalytic Wittig and Mitsunobu Reactions
02/02/2012US20120029210 Process for the synthesis of strontium ranelate and its hydrates
02/02/2012US20120029048 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies
02/02/2012US20120029034 Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents
02/02/2012US20120029013 Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products
02/02/2012US20120028985 Combinational therapy for treating autoimmune disease
02/02/2012US20120028977 Subunit Selective NMDA Receptor Potentiators For The Treatment Of Neurological Conditions
02/02/2012US20120028804 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
02/02/2012CA2805766A1 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies
02/01/2012EP2411361A1 1,1,1-trifluoro-2-hydroxypropyl compounds
02/01/2012EP2411358A1 Leukotriene b4 inhibitors
02/01/2012CN102336738A Synthesis method of 2-thiopheneethamine
02/01/2012CN102336679A 7-substituted tetracycline compounds
01/2012
01/31/2012US8106213 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
01/31/2012US8106192 Method for producing 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
01/31/2012US8106095 modulators of peroxisome proliferator activated receptors; treating diabetes, polycystic ovary syndrome, hypertension, ischemia, stroke, irritable bowel disorder, inflammation, cardiovascular diseases; dyslipidema; [4-[[2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]thio]-2-methylphenoxy]-acetic acid
01/31/2012US8106091 Inhibitors of IKK-beta serine-threonine protein kinase
01/31/2012CA2391952C Inhibitors of histone deacetylase
01/26/2012WO2012012278A2 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex
01/26/2012WO2012011125A1 Agonists of gpr40
01/26/2012WO2011150457A3 Haematopoietic-prostaglandin d2 synthase inhibitors
01/26/2012US20120022272 Oxidative desulfurization using a titanium(iv) catalyst and organohydroperoxides
01/26/2012US20120022116 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex
01/26/2012US20120022080 Plasminogen Activator Inhibitor-1 Inhibitor
01/26/2012US20120018710 Novel polymerizable monomer and polymer of the polymerizable monomer, and material for organic device, hole injection/transport material and organic electroluminescent element each comprising the polymer
01/26/2012CA2805808A1 Agonists of gpr40
01/25/2012EP2409973A1 New crystal form and pharmaceutical compositions of (+)-R-zileuton
01/25/2012EP2408770A2 Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
01/25/2012EP2408763A2 Derivatives of n-ý(2-aza-bicycloý2.1.1¨hex-1-yl)-aryl-methyl¨-heterobenzamide, preparation thereof and application of same in therapeutics
01/25/2012EP2408760A1 Thiophenyl sulfonamides for the treatment of alzheimer's disease
01/25/2012EP2408743A1 Carbamate derivatives in particular for the treatment of neurological disorders
01/25/2012EP2100877B1 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs
01/25/2012CN1558759B 病毒聚合酶抑制剂 Viral polymerase inhibitors
01/25/2012CN102333760A Halogen-containing organosulfur compounds and use thereof for controlling arthropod pest
01/25/2012CN102329299A Star-shaped oligothiophene derivative, preparation method and application thereof
01/24/2012US8101782 Compounds that inhibit cholinesterase
01/24/2012US8101651 Compounds with activity at estrogen receptors
01/24/2012US8101650 Method for treating a immunology-related disease
01/24/2012US8101640 Antibacterial agents
01/24/2012CA2459577C An enantiomerically pure opioid diarylmethylpiperazine and methods of using same
01/19/2012WO2012009472A2 Structure, synthesis, and applications for oligo phenylene ethynylenes (opes)
01/19/2012WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof
01/19/2012WO2011109551A3 Compounds that modulate intracellular calcium
01/19/2012US20120016014 Benzothiophene carboxamide compounds, composition and applications thereof
01/19/2012US20120015990 Taspase1 inhibitors and their uses
01/19/2012US20120015978 Therapeutic agents for ocular hypertension
01/19/2012US20120015928 Amido Compounds And Their Use As Pharmaceuticals
01/19/2012US20120015911 Method and compositions for treating amyloid-related diseases
01/19/2012US20120015297 Resist composition, method of forming resist pattern, novel compound, and acid generator
01/19/2012DE102010027099A1 Flüssigkristallines Medium mit Stabilisator Liquid-crystalline medium with stabilizer
01/18/2012EP2407465A1 Conjugated compound, and organic thin film and organic thin film element each comprising same
01/18/2012EP2407464A1 Branched compound, and organic thin film and organic thin film element each comprising same
01/18/2012EP2407459A1 Synthetic intermediate in the production of a sulfonamide derivative having PGD2 receptor antagonistic activity
01/18/2012EP2285836B1 Photoinitiator mixtures
01/18/2012EP1919907B9 Heterocyclic compound
01/18/2012EP1546138B1 Raloxifene l-lactate or a hemihydrate thereof, their uses, pharmaceutical compositions and preparation processes
01/18/2012CN102325763A Sulfamides as TRPM8 modulators
01/18/2012CN102325762A Thiophene derivates and liquid crystal media comprising the same
01/18/2012CN102325761A Thiophene compounds for liquid-crystalline media
01/18/2012CN102325750A Sulfonamides as trpm8 modulators
01/18/2012CN102321068A Method for preparing strontium ranelate
01/18/2012CN102321067A Preparation method of articaine hydrochloride
01/18/2012CN102321066A Method for producing aryl-aminopropanols
01/18/2012CN102320908A Preparation method of beta-amino acids or derivatives of beta-amino acids
01/18/2012CN101107226B Phenoxyacetic acid derivatives useful for treating respiratory diseases
01/17/2012US8097759 Inflammatory cytokine release inhibitor
01/17/2012US8097649 Composition and method for stabilizing the same
01/17/2012US8097611 Sulfonyl-derivatives as novel or histone deacetylase
01/12/2012WO2012006070A1 Compounds and methods for the treatment or prevention of flavivirus infections
01/12/2012WO2012006060A1 Compounds and methods for the treatment or prevention of flavivirus infections
01/12/2012WO2012006055A2 Compounds and methods for the treatment or prevention of flavivirus infections
01/12/2012WO2012005310A1 Fluorinated aromatic compound, organic semiconductor material, and organic thin-film device
01/12/2012US20120010187 Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
01/12/2012CA2803248A1 Compounds and methods for the treatment or prevention of flavivirus infections
01/11/2012EP2405505A1 Organic semiconductor material and organic thin film transistor
01/11/2012EP2404915A1 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives
01/11/2012CN102311303A Organic EL device
01/10/2012US8093408 Antidepressant oral pharmaceutical compositions
01/10/2012US8093407 Crystalline duloxetine hydrochloride
01/10/2012US8093241 Acid amide derivatives, process for their production and pesticides containing them
01/10/2012US8092857 Thiophene derivative and organic electroluminescent element
01/05/2012WO2012002203A1 Β-aminocarbonyl compound production method
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 329